Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX plus radiotherapy in patients with borderline resectable pancreatic cancer-The A021501 Trial - In reply Correspondence


Authors: Katz, M. H. G.; Herman, J. M.; O'Reilly, E. M.
Title: Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX plus radiotherapy in patients with borderline resectable pancreatic cancer-The A021501 Trial - In reply
Keywords: fluorouracil; neoadjuvant therapy; pancreatic neoplasms; antineoplastic agent; antineoplastic combined chemotherapy protocols; pancreas tumor; humans; human
Journal Title: JAMA Oncology
Volume: 9
Issue: 2
ISSN: 2374-2437
Publisher: American Medical Association  
Date Published: 2023-02-01
Start Page: 277
End Page: 278
Language: English
DOI: 10.1001/jamaoncol.2022.6147
PUBMED: 36454565
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 March 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly